Eprobemide

Concentration 10,000 +/- 100 ug/ml Matrix: 5% Nitric acid NIST Traceable

Mse A-Ckn CD8b-PE 0.1 mg

Pinatuzumab (anti-CD22) is a CD22 monoclonal antibody. Pinatuzumab targets the cell-surface antigen CD22. Pinatuzumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including non-Hodgkin lymphoma

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the